Dasalieva 50mg

Dasalieva 50mg Tablet contains the active ingredient Dasatinib. It is indicated for use in adults and children over one year of age who have Chronic Myeloid Leukemia. This medication is utilized to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) during the chronic phase, as well as Ph+ acute lymphoblastic leukemia in patients who have not responded to other treatments. Chronic Myeloid Leukemia is a type of blood cancer characterized by the excessive production of white blood cells due to changes in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most prevalent form of blood cancer in children, where the lymphocytes, a type of white blood cell, proliferate rapidly and have an extended lifespan.

Common side effects associated with Dasalieva 50mg Tablet may include diarrhea, headache, cough, rash, nausea, fatigue, vomiting, muscle pain, weakness, and fluctuations in appetite or blood pressure. If these side effects become bothersome or persist, please inform your doctor.

Notify your physician if you have any allergies to Dasatinib or its components. Prior to commencing treatment with this medication, it is important to inform your healthcare provider if you have any liver or heart conditions, respiratory issues, chest pain, a cough, hepatitis B infection, or bleeding disorders. This medication may lead to a significant decrease in the levels of platelets, white blood cells (WBC), or red blood cells (RBC) in the bloodstream. Ensure that your doctor regularly monitors your blood levels. Additionally, inform your healthcare professional about all medications you are currently taking, including prescription drugs, over-the-counter medications, vitamins, antacids, and herbal supplements. This medication is not recommended for children under one year of age.